{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:16Z","timestamp":1792831036889,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110581","type":"journal-article","created":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:24:32Z","timestamp":1790486672000},"page":"110581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-\u03baB signaling and disrupting mitochondrial homeostasis"],"prefix":"10.1016","volume":"183","author":[{"given":"Zhiqiang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7205-5770","authenticated-orcid":false,"given":"Jun","family":"Xv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bioorg.2026.110581_bb0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","article-title":"Colorectal cancer epidemiology: recent trends and impact on outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110581_bb0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ags3.12061","article-title":"Recent updates in the surgical treatment of colorectal cancer","volume":"2","author":"Matsuda","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"15","key":"10.1016\/j.bioorg.2026.110581_bb0015","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal cancer chemotherapy: the evolution of treatment and new approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110581_bb0020","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejso.2020.09.017","article-title":"Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin","volume":"47","author":"Nagourney","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110581_bb0025","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3390\/cancers14122928","article-title":"Drug resistance in colorectal cancer: from mechanism to clinic","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110581_bb0030","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110581_bb0035","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-08-2023","article-title":"Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition","volume":"69","author":"Dallas","year":"2009","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110581_bb0040","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbabio.2017.01.012","article-title":"Mitochondria and cancer chemoresistance","volume":"1858","author":"Guerra","year":"2017","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110581_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-022-01313-4","article-title":"Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management","volume":"15","author":"Jin","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110581_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071707","article-title":"PGC-1\u03b1 controls mitochondrial biogenesis in drug-resistant colorectal cancer cells by regulating endoplasmic reticulum stress","volume":"20","author":"Yun","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110581_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.coemr.2019.02.002","article-title":"Mitochondrial regulator PGC-1a\u2014modulating the modulator","volume":"5","author":"Miller","year":"2019","journal-title":"Curr. Opin. Endocrine Metabolic Res."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110581_bb0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1248\/bpb.23.420","article-title":"Activation of NF-\u03baB determines the sensitivity of human colon cancer cells to TNF\u03b1-induced apoptosis","volume":"23","author":"Han","year":"2000","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2026.110581_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2019.144132","article-title":"Role of the NF-\u03baB signaling pathway in the pathogenesis of colorectal cancer","volume":"726","author":"Soleimani","year":"2020","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110581_bb0070","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41417-024-00811-6","article-title":"NF-\u03baB role on tumor proliferation, migration, invasion and immune escape","volume":"31","author":"Khan","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110581_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/diabetology7030053","article-title":"The interplay between reactive oxygen species, glucose metabolism and NF-kB in the pathogenesis of type 2 diabetes","volume":"7","author":"Mirmiranpour","year":"2026","journal-title":"Diabetology"},{"key":"10.1016\/j.bioorg.2026.110581_bb0080","series-title":"Pharmacology of Mitochondria","first-page":"3","article-title":"Nuclear transcription factors in the mitochondria: a new paradigm in fine-tuning mitochondrial metabolism","author":"Sepuri","year":"2016"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110581_bb0085","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110581_bb0090","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","article-title":"Targeting multiple signaling pathways by green tea polyphenol (\u2212)-epigallocatechin-3-gallate","volume":"66","author":"Khan","year":"2006","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110581_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081948","article-title":"Plant-derived bioactive compounds in colorectal cancer: insights from combined regimens with conventional chemotherapy to overcome drug-resistance","volume":"10","author":"Gavrilas","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2026.110581_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2025.1691590","article-title":"Dietary polyphenols as modulators of cell signaling and inflammation in colorectal carcinogenesis","volume":"12","author":"Tan","year":"2025","journal-title":"Front. Nutr."},{"issue":"24","key":"10.1016\/j.bioorg.2026.110581_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27248810","article-title":"Natural polyphenols for treatment of colorectal cancer","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110581_bb0110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.clnu.2013.03.008","article-title":"Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy","volume":"32","author":"Lecumberri","year":"2013","journal-title":"Clin. Nutr."},{"issue":"S24","key":"10.1016\/j.bioorg.2026.110581_bb0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcb.240630508","article-title":"Biology of colorectal and gastric cancer cell lines","volume":"63","author":"Park","year":"1996","journal-title":"J. Cell. Biochem."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110581_bb0120","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1096\/fj.202000767R","article-title":"Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells","volume":"34","author":"Marchetti","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.bioorg.2026.110581_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100949","article-title":"Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy","volume":"46","author":"Winter","year":"2023","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110581_bb0130","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/0008-5472.CAN-11-1674","article-title":"Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells","volume":"72","author":"Zhou","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.110581_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.740720","article-title":"High ATP production fuels cancer drug resistance and metastasis: implications for mitochondrial ATP depletion therapy","volume":"11","author":"Fiorillo","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110581_bb0140","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb3039","article-title":"PGC-1\u03b1 mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis","volume":"16","author":"LeBleu","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110581_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00435","article-title":"Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways","volume":"10","author":"Gureev","year":"2019","journal-title":"Front. Genet."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110581_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137470","article-title":"Innovative strategies to combat 5-fluorouracil resistance in colorectal cancer: the role of phytochemicals and extracellular vesicles","volume":"25","author":"Barathan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110581_bb0155","series-title":"Dokl. Biochem. Biophys.","first-page":"29","article-title":"Dichotomic role of low-concentration EGCG in the oxaliplatin sensitivity of colorectal cancer cells","author":"Wang","year":"2024"},{"issue":"5","key":"10.1016\/j.bioorg.2026.110581_bb0160","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.3390\/ijms26051988","article-title":"Mechanisms and strategies to overcome drug resistance in colorectal cancer","volume":"26","author":"Haynes","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110581_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102326","article-title":"Epigallocatechin-3-gallate (EGCG) alters histone acetylation and methylation and impacts chromatin architecture profile in human endothelial cells","volume":"25","author":"Ciesielski","year":"2020","journal-title":"Molecules"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682601117X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682601117X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:58:07Z","timestamp":1792828687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682601117X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"alternative-id":["S004520682601117X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110581","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin gallate overcomes oxaliplatin resistance in colorectal cancer by suppressing NF-\u03baB signaling and disrupting mitochondrial homeostasis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110581"}}